Drug recommendation for optimization on treatment outcome for MDR/RR-TB based on a multi-center, large scale, retrospective cohort study in China

Author:

Fan Lin1ORCID,Yang Ming2,Han Yu-Tong34,Ren Fei5,Wang Hua6,Ma Jin-Bao5,Zhu Guo-Hui2,Xiong Yan-Jun6,Fan Xin-Xin7,Chen Su-Xia7,Wu Hao-Yu8,Sun Wen-Wen1,Zhang Shao-Jun1,Ke Hui1,Cheng Xiao-Hong7,Xu Biao34,Chen Yu8,Chen Chang1

Affiliation:

1. Department of Tuberculosis, Shanghai Clinical Research Center for Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai Clinical Research Center for Tuberculosis, Shanghai Key Lab of Tuberculosis, Shanghai, China

2. Department of Tuberculosis, Public Health Clinical Center of Cheng Du, Chengdu, China

3. Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China

4. Key Laboratory of Health Technology Assessment, National Health Commission of the People’s Republic of China (Fudan University), Shanghai, China

5. Department of Tuberculosis, West Section of HangTian Avenue, Xi’an Chest Hospital, Xi’an, Shanxi Province, China

6. Department of Tuberculosis, Anhui Chest Hospital, Hefei, Anhui, China

7. Department of Tuberculosis, The Pulmonary Hospital of Fuzhou, Fu Zhou, Fujian Province, China

8. Department of Tuberculosis, Shenyang Tenth People’s Hospital (Shenyang Chest Hospital), Shenyang, China

Funder

National Natural Science Foundation of China

the Shanghai Science and Technology Committee Fund

the Clinical Research Foundation of Shanghai Pulmonary Hospital

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3